K. Mullertegethoff et al., EVALUATION STUDIES ON THE IN-VITRO RAT HEPATOCYTE MICRONUCLEUS ASSAY, Mutation research. Section on environmental mutagenesis and related subjects, 335(3), 1995, pp. 293-307
Based on a previous study with 8 chemicals (Muller et al., 1993) the a
pplicability of the in vitro rat hepatocyte micronucleus assay was eva
luated by testing a further 21 compounds of different chemical classes
. The obtained results are in good agreement with the known genotoxic
profiles of about 90% of the in total tested compounds. Several known
mutagens and carcinogens, i.e., alkylating agents, aromatic amines, ni
trosamines, nitro compounds, cross-linking agents, and pyrrolizidine a
lkaloids gave clear positive results in this assay, whereas all of the
tested non-carcinogens were negative. The hepatocyte micronucleus ass
ay was shown to distinguish between carcinogenic/non-carcinogenic isom
ers, such as 2- and 4-acetylaminofluorene (AAF) and 2- and 1-nitroprop
ane (NP). Furthermore, the non-genotoxic nature of several hepatocarci
nogens, i.e., the peroxisome proliferating agents fenofibrate, nafenop
in, Wy-14,643, diethyl(hexyl)phthalate (DEHP), and the sedative phenob
arbital, could be confirmed in this assay. The hepatocarcinogen coumar
in exerted mitogenic but no mutagenic properties in the rat hepatocyte
micronucleus assay. This compound may act as a liver tumor promoter.
Benzo[a]pyrene (B[a]P) and 7,12-dimethylbenzanthacene (DMBA), both bel
onging to the group of known carcinogenic and mutagenic polycyclic aro
matic hydrocarbons, failed to induce micronucleus formation in rat hep
atocytes. The high susceptibility of in vitro proliferating hepatocyte
s to mitotic inhibition, exerted by the strong cytotoxic actions of th
ese compounds, seems to be responsible for these negative results. A s
trongly reduced mitotic activity can prevent the formation of micronuc
lei, even when clastogenic effects may have occurred. In the present s
tage, the in vitro rat hepatocyte micronucleus assay cannot be recomme
nded for screening genotoxicity testing. It should rather be used for
special purposes, e.g., when liver-specific mutagenic effects are expe
cted.